ArisGlobal Announces XDI NavaX Data Intelligence, Three New Agents, and NavaX Translation

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE

MADRID, Feb. 11, 2026 /PRNewswire/ — ArisGlobal, an AI-first technology company at the forefront of Life Sciences and creator of LifeSphere®, has announced five significant new product offerings to drive cross-functional operationalization of AI. On day one of Breakthrough 2026, its annual industry event, the company unveiled XDI, its next‑generation data intelligence cortex, three new AI agents, and NavaX Translation for PV case data intake workflows. 

XDI – Explainable AI and evidential alignment beyond functional boundaries 

XDI is ArisGlobal’s next‑generation data intelligence cortex that can access data from multiple functions and systems to enable consistent, explainable decisions within and across the pharma R&D enterprise. Unlike tools that simply accelerate steps within a single workflow, XDI creates a system-agnostic foundation that unifies meaning, context, and intent – ensuring that decisions across Safety, Regulatory, Clinical, Quality, Manufacturing, and all other functions are grounded in shared meaning, aligned evidence, and uniform governance. This will promote confident AI adoption and operationalization, while reducing risk and interpretive drift between teams and use cases. 

New agents for Regulatory Intelligence, Change Distribution, and Signals 

ArisGlobal has also expanded its NavaX Agents Suite portfolio with three powerful new agents; 

NavaX Translation – Transforming global case data intake workflows 

ArisGlobal now supports certified translation capabilities integrated directly into case data intake workflows, via a strategic partnership with TransPerfect Life Sciences. Intelligent language detection routes non-English safety forms instantly for translation using pharma-specific language models and expert linguists. The seamless API integration returns translated forms directly into LifeSphere, eliminating manual effort and dramatically accelerating global pharmacovigilance. By combining NavaX with TransPerfect, translation management time drops from roughly five hours per case to under a minute—delivering unmatched automation, speed, and accuracy in the market. 

“The challenge for life sciences isn’t just adopting AI – it’s operationalizing it at scale with consistency, governance, and real business impact. With these latest product enhancements, we’re continuing to enable organizations to move from experimentation to production, turning AI into a reliable foundation for enterprise decision-making,” commented Aman Wasan, CEO of ArisGlobal. 

“We’re witnessing a fundamental shift in how technology empowers life sciences teams. These innovations represent the evolution from automating individual tasks to orchestrating intelligence across entire operational ecosystems, enabling smarter decisions, faster insights, and truly scalable AI adoption,” said Ann-Marie Orange, CIO and Global Head of R&D at ArisGlobal. 

Breakthrough 2026, held in Madrid, Spain, brings together top executives, industry leaders, and experts to explore the theme of “Operationalizing AI”, showcasing how proven AI use cases are transforming into everyday practice across life sciences. 

For more information, visit https://www.arisglobal.com/breakthrough or follow ArisGlobal on LinkedIn. 

About ArisGlobal 

ArisGlobal is a leading life sciences technology company and provider of cloud-based software solutions for pharmacovigilance, regulatory affairs, quality management, and medical affairs. LifeSphere®, the company’s unified product platform, delivers a powerful combination of domain expertise, advanced technology, and analytics to help life sciences organizations transform compliance into a strategic advantage. ArisGlobal serves more than 300 customers globally, including many of the world’s top pharmaceutical, biotechnology, and medical device companies. For more information, visit www.arisglobal.com. 

Logo – https://mma.prnewswire.com/media/1510670/ArisGlobal_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/arisglobal-announces-xdi-navax-data-intelligence-three-new-agents-and-navax-translation-302684858.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire